Reply  by Nihoyannopoulos, Petros & Oakley, Celia M.
1304 LEITERS TO THE EDITOR 
control subjects that could have limited the observed exercise 
capacity in the patients. 
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Reply 
The aim of our study was not to list known potential influences on 
Doppler diastolic indexes but to relate those indexes to the patient's 
professed symptomatic status and exercise capacity so that each 
patient in effect served as his or her own control. Our patient group 
was closely matched with a normal group for comparison of Doppler 
indexes and exercise capacity. No patient had significant mitral 
incompetence and all had normal findings on coronary angiography 
at a time unrelated to the current study. Although beta-adrenergic 
blocking agents may have a limiting effect on oxygen uptake in 
trained men (I), in patients with hypertrophic cardiomyopathy, 
these agents have a beneficial effect on diastolic function and patient 
symptoms (2,3). Verapamil is more likely to alter diastolic indexes 
and has a tendency to normalize them (4). However, only four of our 
patients were taking verapamil during the study and their inclusion 
does not influence our results in 40 patients. 
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Correction 
A correction should be made to Table 2 in the article by Rihal et al. 
in the May issue of the Journal (Rihal CS, Gersh BJ, Whisnant JP, 
et al. Influence of coronary heart disease on morbidity and mortality 
after carotid endarterectomy: a population-based study in Olmsted 
County, Minnesota [1970-1988]. J Am Coll Cardiol 1992;19:1254-
60). The numbers in the last line of Table 2 were incorrectly 
transposed from Table 1. The authors apologize for the error and 
provide the following corrected version: 
Table 2: Distribution of All Postoperative Cardiac Events Through 
July I, 1989 Among Olmsted County Residents Who Underwent 
Carotid Endarterectomy During the Period 1970 to 1988 
Group I Group 2 Group 3 Total 
No. % No. % No. % No. % 
Cardiac death 8 9 IS 23 6 30 29 16 
Myocardial infarction 13 14 20 31 5 25 38 21 
CABG orPTCA 4 4 19 30 4 20 27 15 
Pulmonary edema 4 4 7 II 5 12 7 
Ventricular tachycardia 3 3 9 14 3 15 15 8 
Patients with ~ I event 21 23 40 63 10 50 71 40 
Definitions and abbreviations as in 'Table I. 
